Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-01-11

Clinical Trial Update: A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

View source ↗

Summary

A retrospective non-interventional study evaluated the real-world use of Seroquel XR and Seroquel IR in inpatients with schizophrenia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL XR (Quetiapine)
  • Seroquel IR (quetiapine fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED